Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

7.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

185
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
185
Study Design in Statistics01:15

Study Design in Statistics

9.3K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
9.3K
Regression Toward the Mean01:52

Regression Toward the Mean

6.5K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.5K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

812
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
812
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

566
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
566

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RankVar: machine learning-based variant ranking and reinterpretation for rare genetic diseases.

Genome medicine·2026
Same author

Improving Retrieval-Augmented Generation without Taxonomy-based Error Categorization.

Proceedings of the conference. Association for Computational Linguistics. Meeting·2026
Same author

Evaluating unsupervised and rule-based phenotyping methods versus administrative code counts for systemic sclerosis identification.

Seminars in arthritis and rheumatism·2026
Same author

Hard to Halt: Automation Bias in Agent-Driven Sequencing Prior Authorization Workflows.

medRxiv : the preprint server for health sciences·2026
Same author

Unsupervised characterization of 100,272 EHR patients identifies high-risk groups and comorbidities linked to premature aging.

NPJ digital medicine·2026
Same author

TimeX: Phenotype Onset Extraction from Clinical Narratives.

npj health systems·2026

Related Experiment Video

Updated: Sep 22, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

Data-Driven Modeling of Randomized Controlled Trial Outcomes.

Zhehuan Chen1, Yilu Fang1, Hao Liu1

  • 1Department of Biomedical Informatics, Columbia University, New York, NY, USA.

Studies in Health Technology and Informatics
|May 25, 2022
PubMed
Summary
This summary is machine-generated.

Clinical trial outcome reporting often uses complex language, hindering standardization. This study proposes a data-driven approach to model trial outcomes, improving natural language processing for research publications.

Keywords:
knowledge representationoutcomerandomized controlled trials

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

718

Related Experiment Videos

Last Updated: Sep 22, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

718

Area of Science:

  • Clinical research informatics
  • Natural language processing in medicine
  • Biomedical data science

Background:

  • A significant portion of randomized controlled trial (RCT) publications feature complex clinical outcome descriptions.
  • Current terminologies lack the capacity to standardize diverse outcome attributes like measures, temporal aspects, and quantitative metrics.
  • This complexity poses challenges for data extraction and analysis in clinical research.

Purpose of the Study:

  • To analyze semantic patterns within clinical outcome text from COVID-19 trials.
  • To develop and present a data-driven method for modeling clinical trial outcomes.
  • To address the limitations of existing terminologies in standardizing outcome reporting.

Main Methods:

  • Analysis of semantic patterns in outcome descriptions from a sample of COVID-19 randomized controlled trials.
  • Development of a data-driven methodology for representing and modeling clinical outcomes.
  • Evaluation of the applicability of the proposed method for natural language processing tasks.

Main Results:

  • Identified prevalent semantic patterns in clinical outcome reporting within the studied trials.
  • Demonstrated the feasibility of a data-driven approach for outcome modeling.
  • Highlighted the inadequacy of existing systems for comprehensive outcome standardization.

Conclusions:

  • A data-driven knowledge representation offers a promising solution for enhancing the natural language processing of clinical outcome text.
  • Standardizing outcome reporting through data-driven methods can improve the accessibility and interpretability of clinical trial findings.
  • Further development of such methods is crucial for advancing clinical research informatics.